Skip to main content
. 2007 Mar 6;96(7):1147–1152. doi: 10.1038/sj.bjc.6603667

Table 1. Proportion of childhood (0–14 years) haematological patients having relapsed according to survival status, diagnosed between 1974–2003 in Yorkshire, UK.

    Patients alive at 31 May 2006
Deceased patients
All registered patients
 
ICCCa   Ever relapsed
Ever relapsed
Ever relapsed
 
group Diagnostic group Yes (%) No (%) Yes (%) No (%) Yes (%) No (%) Total
I Leukaemia 78 (15.2%) 435 (84.8%) 199 (58.0%) 144 (42.0%) 277 (32.4%) 579 (67.6%) 856
Ia  Acute lymphoid leukaemia 66 (15.0%) 375 (85.0%) 162 (69.8%) 70 (30.2%) 228 (33.9%) 445 (66.1%) 673
Ib  Acute myeloid leukaemia 12 (20.7%) 46 (79.3%) 31 (34.4%) 59 (65.6%) 43 (29.1%) 105 (70.9%) 148
Ic–e  Other leukaemiab 0 (0.0%) 14 (100.0%) 6 (28.6%) 15 (71.4%) 6 (17.1%) 29 (82.9%) 35
II Lymphoma 27 (11.9%) 200 (88.1%) 38 (40.4%) 56 (59.6%) 65 (20.2%) 256 (79.8%) 321
IIa  Hodgkin's lymphoma 16 (13.3%) 104 (86.7%) 5 (33.3%) 10 (66.7%) 21 (15.6%) 114 (84.4%) 135
IIb  Non-Hodgkin's lymphoma 10 (13.5%) 64 (86.5%) 26 (43.3%) 34 (56.7%) 36 (26.9%) 98 (73.1%) 134
IIc–e  Other lymphomab 1 (3.0%) 32 (97.0%) 7 (36.8%) 12 (63.2%) 8 (15.4%) 44 (84.6%) 52
  Total 105 (14.2%) 635 (85.8%) 237 (54.2%) 200 (45.8%) 342 (29.1%) 835 (70.9%) 1177
a

ICCC: International Classification of Childhood Cancer (Kramárová et al, 1996).

b

Excluded from main analyses.